Sensus Healthcare, Inc. Stock Analysis & AI Score
Sensus Healthcare, Inc. (SRTS) has an ST Score of 48.8 (C+), driven by its Financial Strength (A+) and held back by its Profitability (D). Analysts rate it Buy with a $4.75 price target (+63.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Sensus Healthcare, Inc. (SRTS) has an ST Score of 48.8 (C+), driven by its Financial Strength (A+) and held back by its Profitability (D). Analysts rate it Buy with a $4.75 price target (+63.2% upside).
- Strongest
- Financial StrengthA+
- Weakest
- ProfitabilityD
All factor grades
- Financial StrengthA+
- ForecastB+
- ValuationB
- GrowthC+
- MomentumC
- ProfitabilityD
- Piotroski2/9
Contact
SRTS stock: frequently asked questions
What is SRTS's ST Score?
Sensus Healthcare, Inc. (SRTS) has an ST Score of 48.8 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SRTS a buy, hold, or sell?
Analysts rate SRTS a Buy, with a price target of $4.75 (+63.2% vs the current price). Our ST Score grades it C+ (48.8/100). The ST Score is a data-driven signal, not a recommendation.
What are SRTS's factor grades?
Valuation B, Profitability D, Financial Strength A+, Momentum C, Growth C+, Forecast B+.
What is SRTS's valuation grade?
Sensus Healthcare, Inc. (SRTS) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SRTS's growth grade?
Sensus Healthcare, Inc. (SRTS) earns a growth grade of C+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SRTS's profitability grade?
Sensus Healthcare, Inc. (SRTS) earns a profitability grade of D, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SRTS's financial strength grade?
Sensus Healthcare, Inc. (SRTS) earns a financial strength grade of A+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SRTS?
The average analyst price target for Sensus Healthcare, Inc. (SRTS) is $4.75 from 9 analysts, which is +63.2% versus the recent price of $2.91.
What is SRTS's Piotroski score?
Sensus Healthcare, Inc. (SRTS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.